Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine

Neuropsychopharmacology

Volumn 37, Issue 3, 2012, Pages 707-722

  Lominac, Kevin D ^a   Sacramento, Arianne D ^a   Szumlinski, Karen K ^a   Kippin, Tod E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

addiction; dopamine; glutamate; methamphetamine; nucleus accumbens; self administration

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DRUG SELF ADMINISTRATION; MALE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; GLUTAMIC ACID; MALE; MEMBRANE GLYCOPROTEINS; METHAMPHETAMINE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; SELF ADMINISTRATION;

EID: 84855904904     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.248     Document Type: Article

References (113)

1. Abekawa T, Ohmori T, Koyama T (1994). Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643:276-281. (Pubitemid 24115101)
2. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S (1990). Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine-an in vivo dialysis study in freely moving rats. Brain Res 507:344-346. (Pubitemid 20054122)
3. Akiyama K, Kanzaki A, Tsuchida K, Ujike H. (1994). Methamphetamine- induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr Res 12:251-257. (Pubitemid 24182407)
4. Arai I, Shimazoe T, Shibata S, Inoue H, Yoshimatsu A, Watanabe S (1996). Enhancement of dopamine release from the striatum through metabotropic glutamate receptor activation in methamphetamine sensitized rats. Brain Res 729:277-280. (Pubitemid 26281273)
5. Arai I, Shimazoe T, Shibata S, Inoue H, Yoshimatsu A, Watanabe S (1997). Methamphetamine-induced sensitization of dopamine release via a metabotropic glutamate receptor mediated pathway in rat striatal slices. Jpn J Pharmacol 73:243-246. (Pubitemid 27170663)
6. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S et al (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6:743-749. (Pubitemid 36792890)
7. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW (2002). The origin and neuronal function of in vivo nonsynatpic glutamate. J Neurosci 22:9134-9141. (Pubitemid 35379084)
8. Battaglia G, Fornai F, Busceti CL, Aloisi G, Cerrito F, De Blasi A (2002). Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J Neurosci 22:2135-2141. (Pubitemid 35386513)
9. Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ (2009). Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res 199:89-102.
10. Berman SM, Kuczenski R, McCracken JT, London ED (2009). Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry 14:123-142.
11. Bradberry CW (2007). Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction. Psychopharmacology 191:705-717. (Pubitemid 46355892)
12. Broom SL, Yamamoto BK (2005). Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats. Psychopharmacology 181:467-476. (Pubitemid 41480895)
13. Bungay PM, Newton-Vinson P, Isele W, Garris PA, Justice Jr JB (2003). Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem 86:932-946. (Pubitemid 36988805)
14. Burrows KB, Nixdorf WL, Yamamoto BK (2000). Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. Pharmacol Exp Ther 292:853-860. (Pubitemid 30136575)
15. Bustamante D, You ZB, Castel MN, Johansson S, Goiny M, Terenius L et al (2002). Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem 83:645-654. (Pubitemid 35231818)
16. Cabib S, Puglisi-Allegra S (1996). Stress, depression and the mesolimbic dopamine system. Psychopharmacology 128:331-342. (Pubitemid 26417674)
17. Camp DM, Browman KE, Robinson TE (1994). The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis vs Fischer 344 rats. Brain Res 668:180-193.
18. Chang L, Alicata D, Ernst T, Volkow N (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 (Suppl 1):16-32. (Pubitemid 46328220)
19. Chefer VI, Zapata A, Shippenberg TS, Bungay PM (2006). Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J Neurosci Methods 155:187-193. (Pubitemid 44251151)
20. Davidson C, Chen Q, Zhang X, Xiong X, Lazarus C, Lee TH et al (2007). Deprenyl treatment attenuates long-term pre-and post-synaptic changes evoked by chronic methamphetamine. Eur J Pharmacol 583:100-110. (Pubitemid 47464210)
21. Di Chiara G, Bassareo V (2007). Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7:69-76. (Pubitemid 46238042)
22. Di Ciano P, Blaha CD, Phillips AG (1996). Changes in dopamine oxidation currents in the nucleus accumbens during unlimited-access self-administration of d-amphetamine by rats. Behav Pharmacol 7:714-729. (Pubitemid 27151858)
23. Di Ciano P, Blaha CD, Phillips AG (2002). Inhibition of dopamine efflux in the rat nucleus accumbens during abstinence after free access to d-amphetamine. Behav Brain Res 128:1-12. (Pubitemid 34033629)
24. Di Ciano P, Coury A, Depoortere RY, Egilmez Y, Lane JD, Emmett-Oglesby MW et al (1995). Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine. Behav Pharmacol 6:311-322.
25. Dworkin SI, Mirkis S, Smith JE (1995). Response-dependent vs response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117:262-266.
26. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008). Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 29:31-49.
27. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008). Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363:3125-3135.
28. Fang YR, Abekawa T, Li XB, Wang ZC, Inoue T, Koyama T (2005). Effect of the protein kinase C inhibitor, staurosporine, on the high dose of methamphetamine-induced behavioral sensitization to diziclopine (MK-801). Psychopharmacology 180:100-106. (Pubitemid 40897076)
29. Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M et al (2005a). Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamineand morphine-induced conditioned place preference in rats. Eur J Neurosci 22:2744-2754. (Pubitemid 41811271)
30. Fujio M, Nakagawa T, Suzuki Y, Satoh M, Kaneko S (2005b). Facilitative effect of a glutamate transporter inhibitor (2S, 3S)-3-\{3-[4-(trifluoromethyl) benzoylamino]benzyloxy\}aspartate on the expression of methamphetamine-induce. J Pharmacol Sci 99:415-418. (Pubitemid 41813434)
31. Galici R, Pechnick RN, Poland RE, France CP (2000). Comparison of noncontingent vs contingent cocaine administration on plasma corticosterone levels in rats. Eur J Pharmacol 387:59-62. (Pubitemid 30035374)
32. Gass JT, Osborne MP, Watson NL, Brown JL, Olive MF (2009). mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology 34:820-833.
33. Golembiowska K, Konieczny J, Wolfarth S, Ossowska K (2003). Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats. Neuropharmacology 45:484-492. (Pubitemid 36936981)
34. Heinz A, Schlagenhauf F (2010). Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull 36:472-485.
35. Ito K, Abekawa T, Koyama T (2006). Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology 187:293-302. (Pubitemid 44079921)
36. Kalivas PW (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561-572.
37. Kapasova Z, Szumlinski KK (2008). Strain differences in alcoholinduced neurochemical plasticity: a role for accumbens glutamate in alcohol intake. Alcohol Clin Exp Res 32:617-631. (Pubitemid 351430429)
38. Kashihara K, Okumura K, Onishi M, Otsuki S (1991). MK-801 fails to modify the effect of methamphetamine on dopamine release in the rat striatum. Neuroreport 2:236-238.
39. Kazahaya Y, Akimoto K, Otsuki S (1989). Subchronic methamphetamine treatment enhances methamphetamine-or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903-912. (Pubitemid 19122766)
40. Kehagia AA, Murray GK, Robbins TW (2010). Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20:199-204.
41. Kerstetter KA, Aguilar VR, Parrish AB, Kippin TE (2008). Protracted time-dependent increases in cocaine-seeking behavior during cocaine withdrawal in female relative to male rats. Psychopharmacology 198:63-75.
42. Kim HS, Jang CG (1997). MK-801 inhibits methamphetamineinduced conditioned place preference and behavioral sensitization to apomorphine in mice. Brain Res Bull 44:221-227.
43. Kippin TE, Szumlinski KK, Kapasova Z, Rezner B, See RE (2008). Prenatal stress enhances responsiveness to cocaine. Neuropsychopharmacology 33:769-782. (Pubitemid 351252685)
44. Knackstedt LA, Melendez RI, Kalivas PW. (2010). Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67:81-84.
45. LaLumiere RT, Kalivas PW (2008). Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28:3170-3177. (Pubitemid 351442289)
46. Lecca D, Cacciapaglia F, Valentini V, Acquas E, Di Chiara G (2007a). Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology 191:653-667. (Pubitemid 46355877)
47. Lecca D, Valentini V, Cacciapaglia F, Acquas E, Di Chiara G (2007b). Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell vs core dopamine in the rat: a repeated sampling microdialysis study. Psychopharmacology 194:103-116. (Pubitemid 47282733)
48. Li Z, Jie L, Gardner EL, Xi ZX (2010). Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats. J Neurochem 114:1368-1380.
49. Madayag A, Kau KS, Lobner D, Mantsch JR, Wisniewski S, Baker DA (2010). Drug-induced plasticity contributing to heightened relapse susceptibility: Neurochemical changes and augmented reinstatement in high-intake rats. J Neurosci 30:210-217.
50. Mantsch JR, Goeders NE (2000). Effects of cocaine self-administration on plasma corticosterone in rats: relationship to hippocampal type II glucocorticoid receptors. Prog Neuro-Psychopharmacol Biol Psychiat 24:633-646. (Pubitemid 30419085)
51. Mark KA, Quinton MS, Russek SJ, Yamamoto BK (2007). Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J Neurosci 27:6823-6831. (Pubitemid 46983446)
52. Mark KA, Soghomonian JJ, Yamamoto BK (2004). High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 24:11449-11456. (Pubitemid 39658280)
53. Marinelli M, Piazza PV (2002). Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16:387-394. (Pubitemid 35471854)
54. Marshall JF, O'Dell SJ, Weihmuller FB (1993). Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J Neural Transm Gen Sect 91:241-254. (Pubitemid 23131306)
55. McFarland K, Lapish CC, Kalivas PW (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaineinduced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537. (Pubitemid 36531996)
56. Melega WP, Williams AE, Schmitz DA, DiStefano EW, Cho AK (1995). Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-96.
57. Miguens M, Del Olmo N, Higuera-Matas A, Torres I, Garcia-Lecumberri, Ambrosio E (2008). Glutamate and aspartate levels in the nucleus accumbens during cocaine self-administration and extinction: a time course microdialysis study. Psychopharmacology 196:303-313.
58. Miyamoto Y, Yamada K, Nagai T, Mori H, Mishina M, Furukawa H et al (2004). Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur J Neurosci 19:151-158. (Pubitemid 38122081)
59. Miyatake M, Narita M, Shibasaki M, Nakamura A, Suzuki T (2005). Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. Eur J Neurosci 22:1476-1488. (Pubitemid 41442419)
60. Mutschler NH, Miczek KA (1998). Withdrawal from a selfadministered or non-contingent cocaine binge: differences in ultrasonic distress vocalizations in rats. Psychopharmacology 135:161-168.
61. Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M (2005). Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res 156:233-239. (Pubitemid 39576063)
62. Nakagawa T, Kaneko S (2008). Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3, 4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N, N-diisopropyltryptamine (foxy). J Pharmacol Sci 106:2-8. (Pubitemid 351159062)
63. Nash JF, Yamamoto BK (1992). Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine. Brain Res 581:237-243.
64. Nishino N, Shirai Y, Kajimoto Y, Kitamura N, Yamamoto H, Yang CQ et al (1996). Increased glutamate transporter (GLT-1) immunoreactivity in the rat striatum after repeated intermittent administration of methamphetamine. Ann NY Acad Sci 801:310-314. (Pubitemid 27029018)
65. Ohmori T, Abekawa T, Koyama T (1995). Environment modifies the expression of behavioral sensitization produced by methamphetamine: behavioral and neurochemical studies. Behav Pharmacol 6:133-142.
66. Ohmori T, Abekawa T, Koyama T (1996). The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 29:301-307. (Pubitemid 26270760)
67. Orejarena MJ, Berrendero F, Maldonado R, Robledo P (2009). Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice. Psychopharmacology 205:457-466.
68. Osborne MP, Olive MF (2008). A role for mGluR5 receptors in intravenous methamphetamine self-administration. Ann NY Acad Sci 1139:206-211.
69. Palamarchouk V, Smagin G, Goeders NE (2009). Self-administered and passive cocaine infusions produce different effects on corticosterone concentrations in the medial prefrontal cortex (MPC) of rats. Pharm Biochem Behav 94:163-168.
70. Parsons LH, Justice Jr JB (1994). Quantitative approaches to in vivo brain microdialysis. Crit Rev Neurobiol 8:189-220. (Pubitemid 24247570)
71. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, Fourth Edition. Academic Press: New York.
72. Pezze MA, Feldon J (2004). Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74:301-320. (Pubitemid 39586721)
73. Piazza PV, Le Moal ML (1996). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378. (Pubitemid 26168703)
74. Pierce RC, Bell K, Duffy P, Kalivas PW (1996). Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1660.
75. Ranaldi R, Pocock D, Zereik R, Wise RA (1999). Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. J Neurosci 19:4102-4109. (Pubitemid 29222282)
76. Rivie're GJ, Byrnes KA, Gentry WB, Owens SM (1999). Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 291:1220-1226.
77. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198. (Pubitemid 16100809)
78. Robinson TE, Berridge KC (2008). The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363:3137-3146.
79. Roesch MR, Calu DJ, Esber GR, Schoenbaum G (2010). All that glitters... dissociating attention and outcome expectancy from prediction errors signals. J Neurophysiol 104:587-595.
80. Sailasuta N, Abulseoud O, Harris KC, Ross BD (2010). Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 30:950-960.
81. Schultz W (2010). Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 6:24.
82. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kalivas PW (2009). Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331:555-562.
83. Shepard JD, Chuang DT, Shaham Y, Morales M (2006). Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology 185:505-513.
84. Shimada A, Yamaguchi K, Yanagita T (1996). Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain. Ann NY Acad Sci 801:361-370. (Pubitemid 27029023)
85. Shimazoe T, Doi Y, Arai I, Yoshimatsu A, Fukumoto T, Watanabe S (2002). Both metabotropic glutamate I and II receptors mediate augmentation of dopamine release from the striatum in methamphetamine-sensitized rats. Jpn J Pharmacol 89:85-88. (Pubitemid 34618613)
86. Shirai Y, Shirakawa O, Nishino N, Saito N, Nakai H (1996). Increased striatal glutamate transporter by repeated intermittent administration of methamphetamine. Psychiatry Clin Neurosci 50:161-164. (Pubitemid 26199094)
87. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003). Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165:359-369. (Pubitemid 36223077)
88. Simões PF, Silva AP, Pereira FC, Marques E, Grade S, Milhazes N et al (2007). Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150:433-441. (Pubitemid 350214497)
89. Simães PF, Silva AP, Pereira FC, Marques E, Milhazes N, Borges F et al (2008). Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Ann NY Acad Sci 1139:232-241.
90. Sonsalla PK, Nicklas WJ, Heikkila RE (1989). Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398-400. (Pubitemid 19047519)
91. Stefanski R, Justinova Z, Hayashi T, Takebayashi M, Goldberg SR, Su TP (2004). Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology 175:68-75. (Pubitemid 39215532)
92. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR (1999). Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371:123-135. (Pubitemid 29216994)
93. Stefanski R, Lee SH, Yasar S, Cadet JL, Goldberg SR (2002). Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration. Eur J Pharmacol 439:59-68. (Pubitemid 34286607)
94. Stephans SE, Yamamoto BY (1995). Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res 700:99-106.
95. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies (2009). The TEDS Report: Trends in Methamphetamine Admissions to Treatment: 1997-2007. Rockville, MD.
96. Suto N, Ecke LE, You ZB, Wise RA (2010). Extracellular fluctuations of dopamine and glutamate in the nucleus accumbens core and shell associated with lever-pressing during cocaine self-administration, extinction, and yoked cocaine administration. Psychopharmacology 211:267-275.
97. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005). Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406-433. (Pubitemid 40834286)
98. Suzuki H, Shishido T, Watanabe Y, Abe H, Shiragata M, Honda K et al (1997). Changes of behavior and monoamine metabolites in the rat brain after repeated methamphetamine administration: effects of duration of repeated administration. Prog Neuropsychopharmacol Biol Psychiatry 21:359-369. (Pubitemid 27149397)
99. Tata DA, Yamamoto BK (2007). Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction 102 (Supplement 1):49-60. (Pubitemid 46328208)
100. Thomas MJ, Kalivas PW, Shaham Y (2008). Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154:327-342. (Pubitemid 351670603)
101. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99-120. (Pubitemid 30646415)
102. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N (2002). Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22:4654-4662. (Pubitemid 37465679)
103. Volz TJ, Fleckenstein AE, Hanson GR (2007). Methamphetamineinduced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 102 (Suppl 1):44-48. (Pubitemid 46328209)
104. Weihmuller FB, O'Dell SJ, Cole BN, Marshall JF (1991). MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res 549:230-235.
105. Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720. (Pubitemid 28137703)
106. Wolf ME (2010). The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci 33:391-398.
107. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL (2006). Cannabinoid CB1 receptor antagonist AM251 inhibits cocaineprimed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 26:8531-8536. (Pubitemid 44316182)
108. Xi ZX, Li X, Peng XQ, Li J, Chun L, Gardner EL et al (2010). Inhibition of n-acetylated-alpa-linked-acidic dipeptidase (NAALADase) by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism. J Neurochem 112:564-576.
109. Xue CJ, Ng JP, Li Y, Wolf ME (1996). Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67:352-363. (Pubitemid 26185617)
110. Yap JJ, Miczek KA (2008). Stress and rodent odels of drug addiction: role of VTA-accumbens-PFC-amygdala circuit. Drug Discov Today Dis Models 5:259-270.
111. Yeh GC, Chen JC, Tsai HC, Wu HH, Lin CY, Hsu PC et al (2002). Amphetamine inhibits the N-methyl-D-aspartate receptormediated responses by directly interacting with the receptor/channel complex. J Pharmacol Ther 300:1008-1016.
112. Zayara AE, McIver G, Valdivia PN, Lominac KD, McCreary AC, Szumlinski KK (2011). Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats. Psychopharmacology 213:321-335.
113. Zhang Y, Loonam TM, Noailles PA, Angulo JA (2001). Comparison of cocaine-and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann NY Acad Sci 937:93-120. (Pubitemid 32613881)